Summary: Immunometric assays were developed for thyrotropin arid thyroglobulin using time-resolved fluorescence äs the measurement signal. The assays were suitable for measurements in serum/plasma or in dry blood spots (3 mm diameter).
Introduction
Screening for iodine deficiency in remote areas is probDry blood spot tests for congenital hypothyroidism in Iematic > because the P^ssing of blood and urine newborns, using thyrotropin änd/or thyroxine äs analyte, sam pl es on-site is often impractical or impossible (5, 6) . has/have become a routine diagnostic tooi (1) (2) (3) . Serum ^ determination of thyrotropin or thyroglobulin and thyrotropin concentration has also been used to assess urinary iodide is only possible in specialised laboraiodine deficiency in recent years (4) .
tories. These problems have led to the search for solu-tions which are practical and which are independent of the geographical location.
This article describes the development and evaluation of dry blood spot assays based on a time resolved fluorescence immunoassay technique, coupled with an infield evaluation using both serum and blood spot samples. Samples were obtained during studies carried out by the International Council for Control of Iodine Deficiency Disorders (ICCIDD) in conjunction with UNICEF.
Preliminary results ftom this group suggest that the most sensitive single quantity for the determination of iodine deficiency is probably thyroglobulin, and not thyrotropin or urinary iodide. We therefore developed an assay for thyroglobulin in dry blood spots and compared it with the determination of thyroglobulin in serum.
The methods used were modifications of methods already published (7, 8) , specially developed for blood spots of 3 mm diameter, using a one-step immunometric assay procedure with biotinylated antibodies and streptavidin-europiuni äs marker substance. Both assays had identical incubation times and could be performed within a single working day.
The dry blood spots could be carried in a brief case at ambient temperature, with no decrease of immunoreactivity over a 28 day period at temperatures between -5 and + 45 °C and relative humidities between < 10 and > 90%. The only precaution was the storage of filter papers in individual cellophane envelopes within 120 minutes after blood sampling.
The studies were carried out on school children in geographical areas of known iodine deficiency. For controls, we used children in the Federal Republic of Germany with normal values for thyroid size and thyroid related analytes (thyrotropin, free thyroxine, free triiodothyronine, antibodies to thyroid peroxidase and thyroglobulin).
Materials and Methods

Materials
Antibodies to thyroglobulin were purchased from DAKO, Hamburg, Germany, those against thyrotropin from Boehringer Mannheim, Mannheim, Germany.
Filter paper for blood spots and whole blood Standards was obtained from Schleicher & Schüll, Dassel, Germany.
Microtitre plates (96-well -Maxisorp) were bought from Nunc, Roskilde, DK.
Standards for thyrotropin (Kabi-Pharmacia, Erlangen, Germany) were made up in EDTA-blood and were calibrated against blood spot Standards for thyrotropin (Pharmacia, Uppsala, Sweden). Stan-< dards for thyroglobulin were made up using Standard material supplied by Henning-Berlin, Berlin, Germany.
Blocking antibodies (MAK-33) and streptavidin were purchased from Boehringer-Mannheim.
Buffer substances and detergents were obtained from Merck, Darmstadt, Germany and Sigrna, Deisenhofen, Germany, Europium-labelling reagent from Pharmacia.
Test kits used for comparison were· purchased from Pharmacia (DELFIA), Henning-Berlin (Lumitest) or Behringwerke, Marburg a. d. L., Germany (Berilux).
Methods
Assays for thyrotropin and thyroglobulin
Two-site immunofluorimetric assays using europium äs signal were developed for thyroglobulin and thyrotropin using microtitre plate technology. The assays could be applied to either serum or dry blood spots.
The liquid phase antibodies were biotinylated, the marker substance being streptavidin-europium. The assay principle was that of dissociated enhanced lanthanide fluorescence (DELFIA). Details of the thyrotropin assay have already been published in this Journal (7) . The thyroglobulin assay was identical to the thyrotropin assay, with the exception of the antibodies, which were the same äs those used for routine analysis (10) .
Serum thyrotropin tests were carried out using the Berilux TSH immunoluminometric assay (Behringwerke). Serum thyroglobulin tests were performed with an in-house immunoluminometric test äs published elsewhere (10), or with the Lumitest Tg assay from Henning-Berlin.
Tables l a and l b show the assay schemes for thyrotropin and thyroglobulin.
Statistics
Non-parametric statistics were used throughout. The Mann-Whitney U-test was used for independent data, the Wilcoxon signed rank test for paired data, the Spearman rank correlätion for data conv parison and the median and relevant percentiles for the central tendency and dispersion parameters. Because of the skewness of distribution of both thyroglobulin and thyrotropin, double logarithmic transformations of the data were carried out for graphical presentation of results.
Subject and Samples
Serum samples (n = 164) were obtained from children in northern India, Algeria and Peru during a study of the International Council for Control of Iodine Deficiency Disorders (ICCIDD), with the support of UNICEF, before and after different regimes of iodine Substitution. The samples were frozen and transported by air to the investigating laboratory, where thyrotropin and thyroglobulin concentrations were determined.
Blood from 304 children in Zimbabwe was spotted onto filter paper, which was then allowed to dry over a two-hour period, before being put into a cellophane envelope. The samples were put into a brief case and delivered to the laboratory 14 days later. The samples were not specially treated and remained at ambient temperature and relative humidity.
The samples were analysed for thyrotropin and thyroglobulin in the laboratory, using identical reagents to those for the serum samples.
A further 54 children from the Chilenen 's hospital in Lübeck, and with no known thyroid disorders, wefe used äs controls. The ana-Tab. l a Assay scheme for the thyrotropin (TSH) assay. 2. Wash the plate with 3 X 300 μΐ demineralised water and pipette 400 μΐ post-coating solution (l g/l bovine serum albumin in 0.05 mol/l carbonate buffer, pH 9.6) and allow to stand for 60 min.
3. Wash the plate with 3 χ 300 μΐ wash solution (0.25 ml/l Triton X-405 in 0.025 mol/l Tris-HCl, pH 7.5). The plate is now ready for use.
b. Assay 1. l blood-spot (3 mm diameter) or 100 μΐ serum. 200 μΐ polyclonal anti-TSH-biotin (sheep) in assay buffer (0.05 mol/l phosphate, 0.07 mol/l NaCl, 0.15 ml/l Triton X-405, l ml/l mouse serum, l ml/l MAK-33, 0.15 mol/l NaN 3 , pH 7.6).
Incubate on a microtitre plate shaker 4 h at ambient temperature. Wash with 6 X 300 μΐ wash solution.
200 μΐ Streptavidin-Eu Incubate and proceed s for thyrotropin assay in table l a.
The assay buffer contained 10 ml/l rabbit serum instead of mouse serum, and no MAK-33 was added.
Standard curve concentrations: 0, 5, 20, 50, 200, 500 μg/l human thyroglobulin (Henning-Berlin) in EDTA blood with a haematocrit of 0.42. Blood was obtained from a thyroidectomised patient with an anti-thyroglobulin titre of less than 10 kU/1 and a thyroglobulin concentration not significantly different from the zeiro Standard in both the Henning kit and in-house assay.
[Serum assay Standards in serum from same patient: 0, l, 5, 10, 50, 250, 1000 μg/l.] lysed blood was EDTA blood drawn for routine laboratory tests. Both plasma and blood spol thyroglobulin was determined. Thyrotropin concentrations were only measured in serum in the control group.
Studies and Results
Evaluation of the assays
The dry blood spot assay for thyrotropin was compared with the Pharmacia DELFIA TSH-kit for neonatal screening. The dry blood spot test for thyroglobulin could not be compared directly with another method.
The thyroglobulin immunofluorimetric assay developed here was compared with the immunoluminometric assay from Henning Berlin on serum samples only, s the latter was not conceived for dry-blood Spots.
Intra-assay precision was determined from precision profiles, inter-assay precision in the accepted manner.
Results are shown in tables 2a and 2b for dry blood spots and in tables 2c and 2d for serum samples.
Comparison of dry blood spot thyrotropin and thyroglobulin concentrations in children from an iodine deficient area in Zimbabwe
The samples were obtained s described above and assayed for thyroglobulin and thyrotropin using the assays depicted in tables l a and Ib. The children were aged between 7 and 13 years (median age 10 years). Thyrotropin fmu/i] Comparison of results before and after treatment, using the Wilcoxon signed rank test, showed p < 0.01 in all cases.
children with thyrotropin levels in the euthyroid ränge, whereas figure Ic shows the scatter for children with elevated thyrotropin levels, i. e. in the overt hypothyroid ränge. Although the thyrotropin levels in figure l a show a positive correlation with thyroglobulin, the elevated thyrotropin levels ( fig. Ic) show a strong negative correlation. Only 28/304 (9.2%) of the children in the Zimbabwe study had elevated thyrotropin concentrations, compared with 182/304 (60%) with elevated thyroglobulin, using cut-off values of 4.5 mU/1 for thyrotropin and 20 g/l for thyroglobulin in blood Spots. 213/304 (70%) children had enlarged thyroid glands. The results show that thyroglobulin is a more sensitive indicator of goitre than thyrotropin in children in an area of severe iodine deficiency.
Results from children uncjer differeiit iodine therapy regimes in Algeria, Peru and India, using serum thyroglobulin and antibodies to thyroid peröxidase äs märkers Four groups of 20 children were each given a different dose of iodine orally in the form of iodised oil (Lipiodol). One gröup of 20 children was given a single injection of iodised oil.
Serum thyroglobulin and antibodies to thyroid peröxi-dase were measured before and one year after treatment.
Only results from children with both of these blood samples have been used, so that the numbers in each group ränge from 8-14 children. The low "recovery rate" was due to the nomadic life pattern of those studied. It is accepted by the authors that these results have only limited statistical validity.
Four dose levels of oral iodine (120, 240, 480 and 960 mg) and one injection of iodised oil (480 mg) were chosen. The results of the thyroglobulin levels are shown in table 3.
It can be seen that the low-level oral iodine regime did not lead to a reduction of serum thyroglobulin to normal levels (Group A), whereas the intermediate regime (Groups B and C) showed increasingly normal thyroglobulin levels one year after therapy. The high dose group (Group D) had, with one exception, normal thyroglobulin levels one year after treatment.
The children given a single injection of iodised oil (group E) showed normal thyroglobulin levels one year later.
There was little difference in the post-treatment thyroglobulin levels of Groups D and E, which showed that a single oral dose of 960 mg iodine, given äs iodised oil, had almost the same effect äs 480 mg iodine given intramuscularly.
In no case were antibodies to thyroid peröxidase positive, either before or after therapy.
Control group of children with no known thyroid disorders
Thyrotropin and thyroglobulin were measured in both dry blood spots and serum from 54 children from the University Children's Hospital in Lübeck.
The median serum thyrotropin level was l .2 mU/1 (ränge 0.26-3.2 mU/1) and median serum thyroglobulin level 18 g/l ränge 2.5-53 g/l). The median dry blood Spot thyrotropin was 0.65 mU/1 (ranging from not detectable (< 0.5 mU/1) to 2.0 mU/1), the median blood Spot thyroglobulin level 12 pg/l (ranging from not detectable (< 2.5 g/l) to 37 g/l). One child with athyroidism had a thyroglobulin level below the detection limit of both serum and dry blood spot assays.
Discussion
The results show that both thyrotropin and thyroglobulin can be assayed in dried blood Spots. This makes the acquisition, storage and transport of samples practical in regions which are either difficult to reach, or which are underdeveloped with regard to modern laboratory technology (5, 6) . It is also probably advantageous to take blood spot samples in areas in which the danger of viral, bacterial or parasite infection is high. The stability of thyroid hormones on filter paper has been documented (9).
The reduction of storage space, not only for samples, but also for sampling devices (syringes, needles, disinfection) means that this approach can be used for field studies in areas previously excluded for practical reasons.
The assays developed here in conjunction with ICCIDD showed the excellent lower detection limits available with time resolved fluorescence labelling. In addition, they provided Information relevant to the development of a strategy for detecting iodine deficiency.
Thus, in agreement with earlier studies (10, 11), thyroglobulin appears to be a more sensitive indicator of iodine deficiency than thyrotropin.
Also, the use of dry blood spot thyroglobulin and thyrotropin neonatal screening would show the absence of the thyroid gland (thyroglobulin levels undetectable) and possibly allow an estimate of the gland size (12) .
Figures Ib and Ic are interesting inasmuch äs they may show a two-phase reaction at the thyroid pituitary level.
In the first phase, the thyroid can compensate for the iodine deficiency by increasing its völume and its potential for thyroxine production. The increased release of thyroglobulin reflects the increase in synthetic activity in the form of scavenging. Not only thyroid hormones, but also their precursors, still attached to thyroglobulin, are released. The result is that the pituitary does not react at this stage, which is reflected by the mainly euthyroid thyrotropin levels. In the second phase, the thyroid gland is no longer able tci secrete enough thyroid hormones or to synthesise sufficient thyroglobulin.
In such cases of advanced goitre with reduced free thyroid hormone levels, the central regulation takes over, resulting in an increase of thyrotropin levels in serum. This has little or no effect on the thyroid hormone production from the däriiaged thyroid, and is reflected in the decrease of thyroglobulin levels in serum.
Further Interpolation of these results may lead to the postulation of two independent mechanisms of thyroid hormone production and control, one operating at the cell nucleus-thyroid level, reflected in figure Ib, and one at the cell nucleüs-thyroid-pituitary level shown in figüre Ic.
The results from the iodine therapy gröups (Groups A-E, table 3) show that even at advanced stages of iodine deficiency, reflected in the grossly elevated thyroglobulin levels in serum, normalisation can be achieved with simple iodine therapy in the form of iodised oil.
Here it can also be seen that although oral iodine application is not äs effective (Group C) when compared with the same amount given by injection (Group E), this can be compensated for by doübling the oral dösage (Group D).
The results from Zimbabwe, together with the results from the iodine therapy group, indicate that serum thyroglobulin is a more sensitive indicator of iodine deficiency than serum thyrotropin and shoüld therefore be used in the diagnosis and control of therapy of iodine deficiency. This may only apply to those areas in the world studied here, in which severe iodine deficiency is still prevalent, but also to countries in which moderate and mild iodine deficiency is present, including large areas of Europe.
It must be borne in mind that these results were obtained from children in areas of extreme iodine deficiency, and may not be transferable to areas of mild deficiency, although results from this laboratory (10) have shown that thyroglobulin levels are elevated in hypothyroid newborns, and that they return to normal under thyroxine treatment. Further studies must be carried out to follow up these fmdings, using serum thyroglobulin, other analytes, and quantities such äs thyroid völume and urinary iodide before and after treatment supplementation. 
